A Lecithinized superoxide dismutase & Inosine, 2',3'-dideoxy- CEP of the European Pharmacopoeia monograph is often referred to as a Lecithinized superoxide dismutase & Inosine, 2',3'-dideoxy- Certificate of Suitability (COS). The purpose of a Lecithinized superoxide dismutase & Inosine, 2',3'-dideoxy- CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Lecithinized superoxide dismutase & Inosine, 2',3'-dideoxy- EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Lecithinized superoxide dismutase & Inosine, 2',3'-dideoxy- to their clients by showing that a Lecithinized superoxide dismutase & Inosine, 2',3'-dideoxy- CEP has been issued for it. The manufacturer submits a Lecithinized superoxide dismutase & Inosine, 2',3'-dideoxy- CEP (COS) as part of the market authorization procedure, and it takes on the role of a Lecithinized superoxide dismutase & Inosine, 2',3'-dideoxy- CEP holder for the record. Additionally, the data presented in the Lecithinized superoxide dismutase & Inosine, 2',3'-dideoxy- CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Lecithinized superoxide dismutase & Inosine, 2',3'-dideoxy- DMF.
A Lecithinized superoxide dismutase & Inosine, 2',3'-dideoxy- CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Lecithinized superoxide dismutase & Inosine, 2',3'-dideoxy- CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Lecithinized superoxide dismutase & Inosine, 2',3'-dideoxy- suppliers with CEP (COS) on PharmaCompass.